These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19435712)

  • 21. Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients.
    Nur E; Brandjes DP; Schnog JJ; Otten HM; Fijnvandraat K; Schalkwijk CG; Biemond BJ;
    Br J Haematol; 2010 Oct; 151(1):62-9. PubMed ID: 20678158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema.
    Boehm BO; Schilling S; Rosinger S; Lang GE; Lang GK; Kientsch-Engel R; Stahl P
    Diabetologia; 2004 Aug; 47(8):1376-9. PubMed ID: 15258735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.
    Haddad M; Perrotte M; Landri S; Lepage A; Fülöp T; Ramassamy C
    J Alzheimers Dis; 2019; 69(3):751-762. PubMed ID: 31127773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced glycation end products in children with chronic renal failure and type 1 diabetes.
    Misselwitz J; Franke S; Kauf E; John U; Stein G
    Pediatr Nephrol; 2002 May; 17(5):316-21. PubMed ID: 12042886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
    Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
    Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced glycation end-products in anterior chamber aqueous of cataractous patients.
    Franke S; Stein F; Dawczynski J; Blum M; Kubetschka U; Stein G; Strobel J
    J Cataract Refract Surg; 2003 Feb; 29(2):329-35. PubMed ID: 12648645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration.
    Hollyfield JG; Perez VL; Salomon RG
    Mol Neurobiol; 2010 Jun; 41(2-3):290-8. PubMed ID: 20221855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
    Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F
    J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress".
    Jadoul M; Ueda Y; Yasuda Y; Saito A; Robert A; Ishida N; Kurokawa K; Van Ypersele De Strihou C; Miyata T
    Kidney Int; 1999 Jun; 55(6):2487-92. PubMed ID: 10354298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of carboxymethyl-lysine (CML) in human cortical bone.
    Thomas CJ; Cleland TP; Sroga GE; Vashishth D
    Bone; 2018 May; 110():128-133. PubMed ID: 29408699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-carboxymethyllysine as a biomarker for coronary artery disease and age-related macular degeneration.
    Stanislovaitienė D; Žaliūnienė D; Steponavičiūtė R; Žemaitienė R; Gustienė O; Žaliūnas R
    Medicina (Kaunas); 2016; 52(2):99-103. PubMed ID: 27170482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of total homocysteine, homocysteine metabolites and of advanced glycation end-products (AGEs) in patients after renal transplantation.
    Franke S; Müller A; Sommer M; Busch M; Kientsch-Engel R; Stein G
    Clin Nephrol; 2003 Feb; 59(2):88-97. PubMed ID: 12608551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A sensitive and specific HPLC method for the determination of total pentosidine concentration in plasma.
    Słowik-Zyłka D; Safranow K; Dziedziejko V; Bukowska H; Ciechanowski K; Chlubek D
    J Biochem Biophys Methods; 2004 Nov; 61(3):313-29. PubMed ID: 15571779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.
    Hanssen NM; Engelen L; Ferreira I; Scheijen JL; Huijberts MS; van Greevenbroek MM; van der Kallen CJ; Dekker JM; Nijpels G; Stehouwer CD; Schalkwijk CG
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1369-73. PubMed ID: 23780372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma pentosidine: a potential biomarker in the management of multiple sclerosis.
    Sternberg Z; Hennies C; Sternberg D; Bistulfi GL; Kazim L; Benedict RH; Chadha K; Leung C; Weinstock-Guttman B; Munschauer F
    Mult Scler; 2011 Feb; 17(2):157-63. PubMed ID: 20965962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked increases in macrophage colony-stimulating factor and interleukin-18 in maintenance hemodialysis patients: comparative study of advanced glycation end products, carboxymethyllysine and pentosidine.
    Uchimura T; Motomiya Y; Okamura H; Hashiguchi T; Miura M; Uji Y; Iwamoto H; Maruyama I
    Nephron; 2002 Apr; 90(4):401-7. PubMed ID: 11961398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
    Hirata K; Kubo K
    Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
    Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
    J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum concentrations of N
    Knani I; Bouzidi H; Zrour S; Bergaoui N; Hammami M; Kerkeni M
    Ann Clin Biochem; 2018 Jul; 55(4):430-436. PubMed ID: 28882063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.